Pfizer breaks ground on sterile injectables plant

Pfizer broke ground Wednesday on a new $450 million pharmaceutical manufacturing facility in Portage, Michigan.

The new 420,000 square foot modular aseptic processing plant will be located on Pfizer's 1,300-acre global manufacturing campus. The facility is expected to bring 450 new jobs to the region. The campus already employs approximately 2,800 people.

Announced in 2018, the construction project is expected to be complete by 2023. Pfizer officials anticipate the facility to be fully in operation in 2025.

Pfizer’s COVID-19 vaccines for U.S. supply are currently being manufactured on the same site, but the new facility will initially manufacture the injectable pain medicine Dynastat, which is shipped internationally but does not have a U.S. FDA approval.

Read the local coverage